Literature DB >> 10773485

Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors.

J L Munoz-Bellido1, S Munoz-Criado, J A Garcìa-Rodrìguez.   

Abstract

Psychotropic drugs have been shown to have antimicrobial activity against several groups of microorganisms. Some of these drugs, such as the new antidepressant agents sertraline, fluoxetine and paroxetine are known to act as efflux pump inhibitors in human cells. Their activity has been studied, alone and combined with antibiotics, against bacterial species, mainly in multiply resistant strains. These agents have surprising activity, mainly against Gram positive microorganisms. They also show synergistic activity when combined with some antibiotics against several bacteria, shown by a decrease in MICs, that converts strains previously resistant to the category of sensitive, and modify physiological aspects related with pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773485     DOI: 10.1016/s0924-8579(99)00154-5

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  51 in total

Review 1.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

Review 2.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 3.  Minireview: Gut microbiota: the neglected endocrine organ.

Authors:  Gerard Clarke; Roman M Stilling; Paul J Kennedy; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Mol Endocrinol       Date:  2014-06-03

4.  Anti-Candida activity of antidepressants sertraline and fluoxetine: effect upon pre-formed biofilms.

Authors:  Ana S Oliveira; José Martinez-de-Oliveira; Gilbert G G Donders; Rita Palmeira-de-Oliveira; Ana Palmeira-de-Oliveira
Journal:  Med Microbiol Immunol       Date:  2018-03-19       Impact factor: 3.402

5.  Comparison of the sensitivity of seven marine and freshwater bioassays as regards antidepressant toxicity assessment.

Authors:  Laetitia Minguez; Carole Di Poi; Emilie Farcy; Céline Ballandonne; Amira Benchouala; Clément Bojic; Carole Cossu-Leguille; Katherine Costil; Antoine Serpentini; Jean-Marc Lebel; Marie-Pierre Halm-Lemeille
Journal:  Ecotoxicology       Date:  2014-09-04       Impact factor: 2.823

Review 6.  Irritable bowel syndrome: a microbiome-gut-brain axis disorder?

Authors:  Paul J Kennedy; John F Cryan; Timothy G Dinan; Gerard Clarke
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

7.  The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.

Authors:  Bing Zhai; Cheng Wu; Linqi Wang; Matthew S Sachs; Xiaorong Lin
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

8.  Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function.

Authors:  Sofia Cussotto; Conall R Strain; Fiona Fouhy; Ronan G Strain; Veronica L Peterson; Gerard Clarke; Catherine Stanton; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2018-08-28       Impact factor: 4.530

Review 9.  Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder.

Authors:  Thomaz F S Bastiaanssen; Sofia Cussotto; Marcus J Claesson; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Harv Rev Psychiatry       Date:  2020 Jan/Feb       Impact factor: 3.732

10.  Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus.

Authors:  Glenn W Kaatz; Varsha V Moudgal; Susan M Seo; Jette E Kristiansen
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.